Sabby Management’s iShares Biotechnology ETF IBB Stock Holding History

Sabby Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-11,372	Closed	-$1.54M	–	130
2020 Q3	$1.54M	Buy	11,372 +2,242	+25%	+$304K	0.23%	53
2020 Q2	$1.25M	Buy	+9,130	New	+$1.16M	0.25%	42

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return

Bank of Nova Scotia Toronto, Ontario, Canada $57.2B AUM 35.3% 1-Year Est. Return

Sabby Management's IBB Position: Q4 2020 in Review

Sabby Management sold out of iShares Biotechnology ETF (IBB) in Q4 2020, closing a stake of 11,372 shares — an estimated $1.54M sold.

Sabby Management first reported a position in IBB in Q2 2020 and held it in 2 quarters. The position peaked at $1.54M in Q3 2020. 856 funds tracked by Wall St. Rank hold IBB as of Q4 2020.

Sabby Management reported no remaining iShares Biotechnology ETF position as of Q4 2020 after selling out during the quarter.
Sabby Management sold 11,372 iShares Biotechnology ETF shares in Q4 2020, an estimated $1.54M.
Sabby Management first reported a position in iShares Biotechnology ETF in Q2 2020 and held it in 2 quarters.
Sabby Management's iShares Biotechnology ETF position peaked at $1.54M in Q3 2020.
856 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2020.

Based on Sabby Management's 13F filing for Q4 2020, filed 16 Feb 2021.